Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (201-210 of 349) with videos related to

Pageof 35
Sort By:
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
Cancers|February 11, 2023
Urinary PSA and Serum PSA for Aggressive Prostate Cancer DetectionNaseruddin Höti, Tung-Shing Lih, Mingming Dong, et al.
BJU International|July 23, 2011
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upEmmanuel S Antonarakis, Zhaoyong Feng, Bruce J Trock, et al.
Urologic Oncology|June 14, 2011
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomyPhillip M Pierorazio, Brian M Lin, Jeffrey K Mullins, et al.
The Journal of Urology|November 17, 2016
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific MortalityWon Sik Ham, Heather J Chalfin, Zhaoyong Feng, et al.
The Journal of Urology|February 16, 2005
Serum leptin and pathological findings at the time of radical prostatectomyStephen J Freedland, Lori J Sokoll, Leslie A Mangold, et al.
Cancer|October 30, 2003
A neurocomputational model for prostate carcinoma detectionPankaj Kalra, Joanna Togami, Gaurav Bansal B S, et al.
The Journal of Urology|November 25, 2003
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?Masood A Khan, H Ballentine Carter, Jonathan I Epstein, et al.
Reviews in Urology|November 25, 2011
Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DCMichael K Brawer, Stacy Loeb, Alan W Partin, et al.
Urology|April 21, 2007
EPCA-2: a highly specific serum marker for prostate cancerEddy S Leman, Grant W Cannon, Bruce J Trock, et al.
Pageof 35

Showing results (201-210 of 349) with videos related to

Sort By:
Pageof 35
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
Cancers|February 11, 2023
Urinary PSA and Serum PSA for Aggressive Prostate Cancer DetectionNaseruddin Höti, Tung-Shing Lih, Mingming Dong, et al.
BJU International|July 23, 2011
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upEmmanuel S Antonarakis, Zhaoyong Feng, Bruce J Trock, et al.
Urologic Oncology|June 14, 2011
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomyPhillip M Pierorazio, Brian M Lin, Jeffrey K Mullins, et al.
The Journal of Urology|November 17, 2016
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific MortalityWon Sik Ham, Heather J Chalfin, Zhaoyong Feng, et al.
The Journal of Urology|February 16, 2005
Serum leptin and pathological findings at the time of radical prostatectomyStephen J Freedland, Lori J Sokoll, Leslie A Mangold, et al.
Cancer|October 30, 2003
A neurocomputational model for prostate carcinoma detectionPankaj Kalra, Joanna Togami, Gaurav Bansal B S, et al.
The Journal of Urology|November 25, 2003
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?Masood A Khan, H Ballentine Carter, Jonathan I Epstein, et al.
Reviews in Urology|November 25, 2011
Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DCMichael K Brawer, Stacy Loeb, Alan W Partin, et al.
Urology|April 21, 2007
EPCA-2: a highly specific serum marker for prostate cancerEddy S Leman, Grant W Cannon, Bruce J Trock, et al.
Pageof 35